Patent Assignment
Reel/Frame 029504/0740
Assignment of Assignor's Interest
Recorded: 2012-12-19
Pages: 26
Assignor
PROMETHEUS LABORATORIES INC.
Executed: 2012-12-04
Assignee
NESTEC S.A.
AVENUE NESTLE 55, VEVEY, CH-1800, SWITZERLAND
Covered Properties
(124)
Inflammatory Bowel Disease First Step Assay System
Patent:
6,218,129 →
Application:
09/079,435 →
Medicaments
Method of Determining Thiopurine Methyltransferase Activity
Methods of Diagnosing Liver Fibrosis
Method of Determining Thiopurine Methyltransferase Acitivity
Methods of diagnosing liver fibrosis
Application:
10/504,544 →
Publication:
US 2006/0084057
Methods of Diagnosing Tissue Fibrosis
Methods of Diagnosing Inflammatory Bowel Disease
Method for optimizing thiopurine efficacy and toxicity using mass spectrometry
Application:
11/274,104 →
Publication:
US 2006/0216726
Methods of Diagnosing Inflammatory Bowel Disease
Method and System for Assisting in Diagnosing Irritable Bowel Syndrome
Patent:
7,943,328 →
Application:
11/679,149 →
Methods of Predicting and Monitoring Tyrosine Kinase Inhibitor Therapy
Methods for Diagnosing Irritable Bowel Syndrome
Application:
11/838,810 →
Publication:
US 2008/0085524
Methods for Diagnosing Irritable Bowel Syndrome
Methods of Diagnosing Inflammatory Bowel Disease
Application:
11/841,699 →
Publication:
US 2008/0182280
Methods for Diagnosing Irritable Bowel Syndrome
Patent:
8,685,741 →
Application:
12/043,082 →
Antibody-Based Arrays for Detecting Multiple Signal Transducers in Rare Circulating Cells
Drug Selection for Lung Cancer Therapy Using Antibody-Based Arrays
Addressable Antibody Arrays and Methods of Use
Application:
12/209,863 →
Publication:
US 2009/0081711
Methods for Diagnosing Irritable Bowel Syndrome
Application:
12/253,177 →
Publication:
US 2010/0094560
Crohn Disease Susceptibility Gene
Application:
12/309,635 →
Publication:
US 2010/0099083
Methods to Predict Risk for Celiac Disease by Detecting Anti-Flagellin Antibody Levels
Patent:
8,409,819 →
Application:
12/392,997 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Methods for Prediction of Inflammatory Bowel Disease (Ibd) Using Serologic Markers
Application:
12/615,983 →
Publication:
US 2010/0129838
Methods of Diagnosing Tissue Fibrosis
Application:
12/695,126 →
Publication:
US 2010/0317022
A Method for Determining the Risk of Crohn's Disease-Related Complications
Biomarkers for Determining Sensitivity of Breast Cancer Cells to HER2-Targeted Therapy
Methods for Diagnosing Irritable Bowel Syndrome
Methods of Diagnosing Inflammatory Bowel Disease
Drug Selection for Gastric Cancer Therapy Using Antibody-Based Arrays
Assays and Methods for the Detection of Crohn's Disease
Patent:
8,445,215 →
Application:
13/190,369 →
Citrullinated Peptides for Diagnosing and Prognosing Rheumatoid Arthritis
Inflammatory Bowel Disease Prognostics
Application:
13/283,511 →
Publication:
US 2012/0171672
Drug Selection for Cancer Therapy by Profiling Signal Transduction Proteins in Ascites or Pleural Efflux Samples
Application:
13/354,257 →
Publication:
US 2012/0270745
Proximity-Mediated Assays for Detecting Oncogenic Fusion Proteins
Application:
13/361,881 →
Publication:
US 2012/0277109
Drug Selection for Colorectal Cancer Therapy Using Antibody-Based Arrays
Application:
13/365,638 →
Publication:
US 2012/0231965
Methods for Diagnosing Irritable Bowel Syndrome
Application:
13/441,658 →
Publication:
US 2012/0315630
Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Methods of diagnosing tissue fibrosis
Application:
60/514,034 →
Inflammatory bowel disease assay system
Application:
60/571,216 →
Methods to optimize thiopurine therapy and reduce toxicity using metabolite profiling and mass spectrometry
Application:
60/628,728 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
60/822,488 →
Methods of Predicting and Monitoring Tyrosine Kinase Inhibitors Therapy
Application:
60/829,812 →
Methods of Diagnosing Irritable Bowel Syndrome
Application:
60/884,397 →
Methods of Diagnosing Intestinal Disorders
Application:
60/893,594 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
60/895,962 →
Antibody-Based Arrays for Detecting Multiple Signal Transducers in Rare Circulating Cells
Application:
60/913,087 →
Drug Selection for Lung Cancer Therapy Using Antibody-Based Arrays
Application:
60/949,820 →
Addressable Antibody Arrays and Methods of Use
Application:
60/972,724 →
Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells
Application:
61/007,527 →
Publication:
US 2008/0076139
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/031,319 →
Methods of Prediction of Inflammatory Bowel Disease (Ibd) Using Serologic Markers
Application:
61/113,537 →
Methods of Prediction of Inflammatory Bowel Disease (Ibd) Using Serologic Markers
Application:
61/118,346 →
Citrullinated Peptides for Diagnosing and Prognosing Rheumatoid Arthritis
Application:
61/164,840 →
Methods of Inflammatory Bowel Disease Prognosis and Biological Response Prediction
Application:
61/169,230 →
Methods of Inflammatory Bowel Disease Prognosis and Biological Response Prediction
Application:
61/178,454 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/187,246 →
Methods to Predict Probability for Surgery in Crohn's Disease Patients
Application:
61/220,453 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
61/220,525 →
Drug Selection for Gastric Cancer Therapy Using Antibody-Based Arrays
Application:
61/225,866 →
Drug Selection for Breast Cancer Theapy Using Antibody-Based Arrays
Application:
61/228,522 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/235,646 →
Pathway Analysis for Herceptin Resistance
Application:
61/241,804 →
Diagnosis and Treatment of Early Onset Rheumatoid Arthritis
Application:
61/243,496 →
Proximity-Mediated Assays for Detecting Oncogenic Fusion Proteins
Application:
61/253,393 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/255,048 →
Diagnosis and Treatment of Early Onset Rheumatoid Arthritis
Application:
61/255,058 →
Methods to Predict Probability for Surgery in Crohn's Disease Patients
Application:
61/255,066 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
61/256,717 →
Methods for Predicting Post-Surgery Risk Associated with Ileal Pouch-Anal Anastomosis
Application:
61/259,978 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/262,856 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/262,877 →
Inflammatory Bowel Disease Prognostics
Application:
61/262,903 →
Methods of Diagnosing Irritable Bowel Syndrome
Application:
61/264,588 →
Novel Genomic Biomarkers for Irritable Bowel Syndrome Diagnosis
Application:
61/264,634 →
Drug Selection for Gastric Cancer Therapy Using Antibody-Based Arrays
Application:
61/265,218 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/265,227 →
Inflammatory Bowel Disease Prognostics
Application:
61/265,324 →
Methods for Prediction of Inflammatory Bowel Disease (Ibd) Using Serologic Markers
Application:
61/265,723 →
Inflammatory Bowel Disease Prognostics
Application:
61/286,356 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/294,433 →
Inflammatory Bowel Disease Prognostics
Application:
61/300,787 →
Inflammatory Bowel Disease Prognostics
Application:
61/302,066 →
Proximity-Mediated Assays for Detecting Oncogenic Fusion Proteins
Application:
61/305,084 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/324,635 →
Drug Selection for Gastric Cancer Therapy Using Antibody-Based Arrays
Application:
61/325,000 →
Methods for Diagnosing Irritable Bowel Syndrome
Application:
61/326,176 →
Proximity-Mediated Assays for Detecting Oncogenic Fusion Proteins
Application:
61/327,487 →
Drug Selection for Breast Cancer Therapy Using Antibody-Based Arrays
Application:
61/328,602 →
Methods for Predicting Post-Surgery Risk Associated with Ileal Pouch-Anal Anastomosis
Application:
61/334,348 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/345,567 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/351,269 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/351,837 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/354,141 →
Proximity-Mediated Assays for Detecting Oncogenic Fusion Proteins
Application:
61/383,037 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/389,672 →
Development of Assays for the Detection of Anti-Tnf Drugs and Autoantibodies
Application:
61/393,581 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/393,588 →
Methods for Optimizing Therapy with Anti-Tnf Drugs
Application:
61/394,269 →
HER2DELTA16 Peptides
Application:
61/419,210 →
Drug Selection for Malignant Cancer Therapy Using Antibody-Based Arrays
Application:
61/426,948 →
Drug Selection for Gastric Cancer Therapy
Application:
61/436,945 →
Drug Selection for Malignant Cancer Therapy Using Antibody-Based Arrays
Application:
61/438,904 →
Drug Selection for Colorectal Cancer Therapy Using Antibody-Based Arrays
Application:
61/439,282 →
Drug Selection for Gastric Cancer Therapy
Application:
61/467,950 →
Profiling of Signal Pathway Proteins in Gastric Cancer
Application:
61/471,678 →
Performance of a Biomarker Panel for Irritable Bowel Syndrome
Application:
61/486,734 →
Methods for Identifying Inflammatory Bowel Disease Patients with Dysplasia and Cancer
Application:
61/497,016 →
Compositions and Methods for Detecting Allelic Variants
Application:
61/525,137 →
Methods for Optimizing Therapy with Anti-Tnf Drugs
Application:
61/528,072 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/550,293 →
Methods for Identifying Inflammatory Bowel Disease Patients with Dysplasia and Cancer
Application:
61/551,330 →
Profiling of Signal Pathway Proteins to Determine Therapeutic Efficacy
Application:
61/553,124 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/553,853 →
Profiling of Signal Pathway Proteins to Determine Therapeutic Efficacy
Application:
61/562,338 →
Drug Selection for Colorectal Cancer Therapy Using Antibody-Based Arrays
Application:
61/562,349 →
Methods for Identifying Inflammatory Bowel Disease Patients with Dysplasia and Cancer
Application:
61/565,445 →
Performance of a Biomarker for Irritable Bowel Syndrome
Application:
61/566,521 →
Profiling of Signal Pathway Proteins to Determine and Monitor Therapeutic Efficacy to PI3K Inhibitors
Application:
61/567,085 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/567,096 →
Methods for Improving Inflammatory Bowel Disease Diagnosis
Application:
61/570,271 →
Compositions and Methods for Detecting Allelic Variants
Application:
61/588,151 →
Profiling of Signal Pathway Proteins in Gastric Cancer
Application:
61/590,787 →
Assays for Measuring Anti-Tnf Drug and Anti-Drug Antibody Levels
Application:
61/646,115 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Dec 29, 2015
From: BANK OF AMERICA, N.A.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 037378/0464 →
Security Interest
Jan 4, 2016
From: SEBELA INTERNATIONAL 2 LIMITED, AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC (SUCCESSOR-IN-INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION), AS AGENT
Reel/Frame 037400/0440 →
Assignment of Assignor's Interest
Jan 13, 2016
From: PROMETHEUS LABORATORIES INC.
To: SEBELA INTERNATIONAL LIMITED
Reel/Frame 037471/0944 →
Merger
Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger.
Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Release of Security Interest
Jun 28, 2019
From: BANK OF AMERICA, N.A.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 049626/0387 →
Merger
Aug 8, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049997/0344 →
Assignment of Assignor's Interest
Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
Change of Name
Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912.
Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Assignment of Assignor's Interest
Feb 8, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES, INC.
Reel/Frame 055256/0976 →
Assignment of Assignor's Interest
Sep 10, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 057452/0129 →